Search

everythinglearnresearchcommunity

for

Search:↓

The medication lopinavir-ritonavir may cause severe hair loss.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Finasteride-loaded ethosomes improve hair loss treatment by targeting pilosebaceous unit.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Six African American women experienced hair loss after switching to a new HIV medication.

Zebrafish larvae are used to study and find treatments for ear cell damage because they are easier to observe and test than mammals.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Created tablet similar to Avodart using γ-cyclodextrin and solubilizers.

A method was developed to test the breakdown of Finasteride capsules, showing it can tell the difference between different brands and highlighting the need for standard tests and ingredient consistency.

COVID-19 can cause various skin issues, but long-term skin problems are rare.